Amarant Pharmaceuticals (Pvt) Ltd.

amarantpharma.com

Amarant Pharma Pharmaceuticals is built on a solid foundation of talented people, unparalleled research and development platform, a strong clinical and commercial presence and trust of its loyal quality conscious prescribers. These factors have enabled Amarant Pharma, in just 6 years, to grow from a bold young startup to a leading pharmaceutical company in Pakistan.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

BUSINESS INSIGHTS

SCA PHARMA NAMES LOUIS PACE AS CHIEF FINANCIAL OFFICER AND CHIEF INFORMATION OFFICER

SCA Pharma | July 15, 2022

news image

SCA Pharma, a nationally recognized leader in the 503B compounding pharmaceuticals outsourcing industry providing quality, service, and value to hospitals nationwide, has announced today the addition of Louis Pace as Chief Financial Officer and Chief Information Officer. Pace brings over 30 years of experience serving several successful private equity backed businesses in functional and P&L leadership roles. Most recently, Mr. Pace served as Chief Financial Officer at Orchid O...

Read More

BUSINESS INSIGHTS, VIEWS AND ANALYSIS

RANCHO BIOSCIENCES WELCOMES BENEVOLENTAI AS FIFTH MEMBER OF SCDS CONSORTIUM

Rancho BioSciences | February 02, 2023

news image

On February 1, 2023, Rancho Biosciences, a leading provider of data sciences services, announced that BenevolentAI has joined the SCDS consortium as its fifth member. Rancho Biosciences launched its Single Cell Data Science (SCDS) pre-competitive consortium on February 26, 2022, with four Charter Members: Bristol Myers Squibb, Janssen Research & Development LLC, a subsidiary of Johnson & Johnson's Janssen Pharmaceutical Companies, Novartis, and Vesalius Therapeutics. ...

Read More

BUSINESS INSIGHTS

SPOTLIGHT THERAPEUTICS APPOINTS VISIONARY GLOBAL PHARMA DRUG DEVELOPER ANTOINE YVER, M.D., M.SC. AS FIRST INDEPENDENT BOARD MEMBER

Spotlight Therapeutics | July 18, 2022

news image

Spotlight Therapeutics, Inc. a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologics, announced the appointment of Antoine Yver, M.D., M.Sc. to the Spotlight Board of Directors. Trained as an oncologist and immunologist, Dr. Yver’s extensive industry experience and perceptive acumen will be extremely valuable as Spotlight continues to strengthen its highly differentiated TAGE platform and advance lead therapeutic candidates towards the c...

Read More

BUSINESS INSIGHTS

ACCORD BIOPHARMA PARTNERS WITH STORYMD TO DELIVER ADVANCED PROSTATE CANCER EDUCATIONAL CONTENT TO CLINICIANS AND PATIENTS

Accord BioPharma | September 21, 2022

news image

Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, announced today a partnership with StoryMD. The StoryMD platform is a single, unified, personalized digital health information portfolio that curates the most relevant, visually rich content based on a patient's condition. Accord BioPharma has signed on as StoryMD's very first corporate partner, to support StoryMD's advanced prosta...

Read More
news image

BUSINESS INSIGHTS

SCA PHARMA NAMES LOUIS PACE AS CHIEF FINANCIAL OFFICER AND CHIEF INFORMATION OFFICER

SCA Pharma | July 15, 2022

SCA Pharma, a nationally recognized leader in the 503B compounding pharmaceuticals outsourcing industry providing quality, service, and value to hospitals nationwide, has announced today the addition of Louis Pace as Chief Financial Officer and Chief Information Officer. Pace brings over 30 years of experience serving several successful private equity backed businesses in functional and P&L leadership roles. Most recently, Mr. Pace served as Chief Financial Officer at Orchid O...

Read More
news image

BUSINESS INSIGHTS, VIEWS AND ANALYSIS

RANCHO BIOSCIENCES WELCOMES BENEVOLENTAI AS FIFTH MEMBER OF SCDS CONSORTIUM

Rancho BioSciences | February 02, 2023

On February 1, 2023, Rancho Biosciences, a leading provider of data sciences services, announced that BenevolentAI has joined the SCDS consortium as its fifth member. Rancho Biosciences launched its Single Cell Data Science (SCDS) pre-competitive consortium on February 26, 2022, with four Charter Members: Bristol Myers Squibb, Janssen Research & Development LLC, a subsidiary of Johnson & Johnson's Janssen Pharmaceutical Companies, Novartis, and Vesalius Therapeutics. ...

Read More
news image

BUSINESS INSIGHTS

SPOTLIGHT THERAPEUTICS APPOINTS VISIONARY GLOBAL PHARMA DRUG DEVELOPER ANTOINE YVER, M.D., M.SC. AS FIRST INDEPENDENT BOARD MEMBER

Spotlight Therapeutics | July 18, 2022

Spotlight Therapeutics, Inc. a biotechnology company applying new insights to develop cell-targeted in vivo CRISPR gene editing biologics, announced the appointment of Antoine Yver, M.D., M.Sc. to the Spotlight Board of Directors. Trained as an oncologist and immunologist, Dr. Yver’s extensive industry experience and perceptive acumen will be extremely valuable as Spotlight continues to strengthen its highly differentiated TAGE platform and advance lead therapeutic candidates towards the c...

Read More
news image

BUSINESS INSIGHTS

ACCORD BIOPHARMA PARTNERS WITH STORYMD TO DELIVER ADVANCED PROSTATE CANCER EDUCATIONAL CONTENT TO CLINICIANS AND PATIENTS

Accord BioPharma | September 21, 2022

Accord BioPharma, the U.S. specialty division of Intas Pharmaceuticals, Ltd., focused on development of oncology, immunology, and critical care therapies, announced today a partnership with StoryMD. The StoryMD platform is a single, unified, personalized digital health information portfolio that curates the most relevant, visually rich content based on a patient's condition. Accord BioPharma has signed on as StoryMD's very first corporate partner, to support StoryMD's advanced prosta...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us